0001593968-23-000080.txt : 20230105 0001593968-23-000080.hdr.sgml : 20230105 20230105164531 ACCESSION NUMBER: 0001593968-23-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COUGHLIN CHRISTOPHER J CENTRAL INDEX KEY: 0001110750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 23512083 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2023-01-03 0001771917 Karuna Therapeutics, Inc. KRTX 0001110750 COUGHLIN CHRISTOPHER J C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 true false false false Option (right to buy) 193.19 2023-01-03 4 A false 321 110.41 A 2033-01-02 Common Stock 321 321 D Option (right to buy) 193.19 2023-01-03 4 A false 407 110.57 A 2033-01-02 Common Stock 407 407 D Option (right to buy) 193.19 2023-01-03 4 A false 67 111.94 A 2033-01-02 Common Stock 67 67 D Option (right to buy) 193.19 2023-01-03 4 A false 181 110.5 A 2033-01-02 Common Stock 181 181 D This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees for board services in 2023. This option vests as to 25% of the shares underlying the option award on each three month anniversary following the vesting commencement date of January 3, 2023. /s/ Troy Ignelzi, Attorney-in-Fact 2023-01-05